← Leaderboards
Jacquelyn Gervay-Hague
University Of Arizona
$1,867,081
Attributed
$1,867,081
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $293.2K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,867,081 · 4
By mechanism
R01$1,158,904 · 1
R21$708,177 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Jon D Rainier$4,282,191
- Pawel R Kiela$7,064,974
- Fayez Khalaf Ghishan$22,629,371
- Michael P Doyle$4,906,195
- Zheshen Zhang$7,317,751
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticGlassFood SafetyGangliosidesAnalytical ToolDrug Design /Synthesis /ProductionAnalogButtermilkBaseFoodborneCell PhysiologyBinding (Molecular Function)C-GlycosideBiologicalBrainAntiaids AgentCombinatorial ChemistryCommunicable DiseasesCommunitiesCarbohydratesCattleDesignDiagnosticGlycolipids
Grant awards (10)
Synthesis and Screening of Bioactive Glycolipids$293,154
R01 · FY2012 · GM · contact PI
Synthesis and Screening of Bioactive Glycolipids$292,917
R01 · FY2011 · GM · contact PI
Synthesis and Screening of Bioactive Glycolipids$284,861
R01 · FY2010 · GM · contact PI
Synthesis and Screening of Bioactive Glycolipids$287,972
R01 · FY2009 · GM · contact PI
Conformationally Biased Scaffolds for Ligand Templating$162,493
R21 · FY2006 · GM · contact PI
Conformationally Biased Scaffolds for Ligand Templating$137,811
R21 · FY2005 · GM
SYNTHESIS OF POTENTIAL HIV-IN AND HIV-RT INHIBITORS$110,938
R21 · FY2001 · GM
SYNTHESIS OF POTENTIAL HIV-IN AND HIV-RT INHIBITORS$788
R21 · FY2001 · GM
DEVELOPMENT OF DRUG DELIVERY SYSTEMS TARGETING HIV ENTRY$182,731
R21 · FY2000 · AI
SYNTHESIS OF POTENTIAL HIV-IN AND HIV-RT INHIBITORS$113,416
R21 · FY2000 · GM